Surface Logix
Latest round
- Series F
Last raised
- Jul 2010
Total raised
- $105M
Investors
- 11
About Surface Logix
, is a drug development company, which creates and develops small molecule drugs to treat metabolic and cardiovascular diseases.
Who invested in Surface Logix
11 investors across 8 rounds
See all investors in Surface Logix
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series F
Jul 16, 2010
Amount
$4M
Investors
Series E
Mar 13, 2009
Amount
$15M
Investors
Series D
Mar 12, 2007
Amount
$20M
Investors
Series D
Oct 28, 2005
Amount
$20M
Investors
Series C
Sep 27, 2005
Amount
$7.8M
Investors
Series C
Apr 19, 2005
Amount
$4.2M
Investors
Series C
Mar 22, 2002
Amount
$22M
Investors
Series B
Nov 10, 2000
Amount
$13M
Investors
Questions about Surface Logix
Who invested in Surface Logix?
Surface Logix has 11 investors on record across 8 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Surface Logix raised?
Surface Logix has raised 8 venture rounds. Sign up free to see how much each round raised and the total.
When did Surface Logix last raise money?
Surface Logix's most recent round on record is a Series F, in Jul 2010.
What does Surface Logix do?
, is a drug development company, which creates and develops small molecule drugs to treat metabolic and cardiovascular diseases.
Where is Surface Logix headquartered?
Surface Logix is headquartered in Brighton, US.
Which VCs invest in companies like Surface Logix?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Surface Logix's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series F
Raising like Surface Logix? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.